FINOTTI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 2.721
AS - Asia 848
EU - Europa 794
SA - Sud America 171
AF - Africa 131
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 7
Totale 4.689
Nazione #
US - Stati Uniti d'America 2.638
SG - Singapore 289
DE - Germania 273
CN - Cina 247
BR - Brasile 122
HK - Hong Kong 121
FI - Finlandia 89
UA - Ucraina 68
IT - Italia 48
SE - Svezia 48
GB - Regno Unito 47
VN - Vietnam 39
PL - Polonia 27
FR - Francia 26
RU - Federazione Russa 21
NL - Olanda 19
BE - Belgio 14
PK - Pakistan 10
GM - Gambi 9
IE - Irlanda 9
PS - Palestinian Territory 9
TR - Turchia 9
BB - Barbados 8
CA - Canada 8
IN - India 8
PR - Porto Rico 8
SA - Arabia Saudita 8
AR - Argentina 7
EC - Ecuador 7
LT - Lituania 7
PY - Paraguay 7
YE - Yemen 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
BD - Bangladesh 6
BG - Bulgaria 6
CI - Costa d'Avorio 6
CR - Costa Rica 6
HU - Ungheria 6
IS - Islanda 6
JM - Giamaica 6
KE - Kenya 6
MA - Marocco 6
MK - Macedonia 6
MY - Malesia 6
NC - Nuova Caledonia 6
PT - Portogallo 6
UY - Uruguay 6
AF - Afghanistan, Repubblica islamica di 5
CD - Congo 5
CG - Congo 5
GA - Gabon 5
GF - Guiana Francese 5
HR - Croazia 5
IQ - Iraq 5
JO - Giordania 5
KH - Cambogia 5
KZ - Kazakistan 5
LA - Repubblica Popolare Democratica del Laos 5
LU - Lussemburgo 5
PH - Filippine 5
TH - Thailandia 5
VE - Venezuela 5
AL - Albania 4
AM - Armenia 4
AU - Australia 4
CV - Capo Verde 4
CW - ???statistics.table.value.countryCode.CW??? 4
DO - Repubblica Dominicana 4
ES - Italia 4
GH - Ghana 4
GN - Guinea 4
IR - Iran 4
LV - Lettonia 4
MD - Moldavia 4
MG - Madagascar 4
MW - Malawi 4
MX - Messico 4
PE - Perù 4
RO - Romania 4
RW - Ruanda 4
SD - Sudan 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TJ - Tagikistan 4
TT - Trinidad e Tobago 4
UG - Uganda 4
AD - Andorra 3
AZ - Azerbaigian 3
BO - Bolivia 3
BS - Bahamas 3
BZ - Belize 3
CL - Cile 3
CM - Camerun 3
CU - Cuba 3
DZ - Algeria 3
GR - Grecia 3
GT - Guatemala 3
HT - Haiti 3
Totale 4.564
Città #
Fairfield 274
Jacksonville 238
Chandler 224
Woodbridge 217
Ann Arbor 198
Singapore 188
Houston 187
Ashburn 179
Wilmington 132
Hong Kong 117
Cambridge 115
Seattle 99
Princeton 77
Boardman 66
Beijing 62
Santa Clara 49
Helsinki 41
Nanjing 40
Roxbury 32
San Diego 32
Des Moines 30
Medford 29
Nürnberg 25
Dong Ket 22
Padova 22
Shenyang 20
Bytom 17
Los Angeles 17
Guangzhou 15
Hebei 13
São Paulo 11
Boston 10
New York 10
Norwalk 9
Redwood City 9
Buffalo 8
Dublin 8
Bridgetown 7
Jinan 7
Ho Chi Minh City 6
Noumea 6
Reykjavik 6
San José 6
Warsaw 6
Abidjan 5
Atlanta 5
Brazzaville 5
Brooklyn 5
Brussels 5
Kingston 5
Kinshasa 5
Kuala Lumpur 5
Libreville 5
Montevideo 5
Nanchang 5
Phnom Penh 5
Skopje 5
Tianjin 5
Abu Dhabi 4
Accra 4
Amman 4
Banjul 4
Brasília 4
Changsha 4
Chicago 4
Conakry 4
Curitiba 4
Dakar 4
Dushanbe 4
Hangzhou 4
Kampala 4
Kigali 4
Lilongwe 4
Ljubljana 4
Luxembourg 4
Nairobi 4
Orange 4
Rome 4
San Francisco 4
Sanaa 4
Santa Cruz 4
Stockholm 4
Tehran 4
Toronto 4
Vienna 4
Vientiane 4
Willemstad 4
Yerevan 4
Aden 3
Amsterdam 3
Andorra la Vella 3
Antakya 3
Antananarivo 3
Antwerp 3
Athens 3
Bamako 3
Bangkok 3
Bishkek 3
Castries 3
Chisinau 3
Totale 3.112
Nome #
Identification and purification from the plasma of Type 1 diabetic subjects of a proteolytically active Grp94Evidence that Grp94 is entirely responsible for plasma proteolytic activity. 252
Crucial role of HSP90 in the Akt-dependent promotion of angiogenic-like effect of Glucose-regulated protein94 (Grp94)-IgG complexes 180
Angiogenic transforming capacity of IgG purified from plasma of type 1 diabetic patients 169
Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immune-stimulating activity on peripheral blood immune cells 167
Long-term blood glucose control and diabetic retinopathy. 160
Structural Insights into Complexes of Glucose-Regulated Protein94 (Grp94) with Human Immunoglobulin G. Relevance for Grp94-IgG Complexes that Form In Vivo in Pathological Conditions 160
Human IgGs induce synthesis and secretion of IgGs and neonatal Fc receptor in human umbilical vein endothelial cells 151
Proteomic investigation on Grp94-IgG complexes circulating in plasma of type 1 diabetic subjects 148
Characterization of immune complexes of idiotypic catalytic and anti-idiotypic inhibitory antibodies in plasma of type 1 diabetic subjects 144
Alteration of plasma proteinase-antiproteinase system in type 1 diabetic patients. Influence of sex and relationship with metabolic control. 142
Comment on: Antibodies to the endoplasmic reticulum-resident chaperones calnexin, Bip and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus 134
Stable complexes formed by Grp94 with human IgG promoting angiogenic differentiation of HUVECs by a cytokine-like mechanism. 133
The role played by serine proteases in the development and worsening of vascular complications in Type 1 diabetes mellitus. 118
Albumin contamination of a purified human alpha1-antitrypsin preparation does not affect either structural conformation or the electrophoretic mobility of the inhibitor. 111
Effects of Glucose-regulated protein94 (Grp94) on Ig secretion from human blood mononuclear cells 107
Mechanism of Na+/K(+)-ATPase activation by trypsin and kallikrein. 107
Biphasic pattern of heparin-induced oxidative degradation of trypsin in the presence of glucose. 102
[Effects of digoxin on plasma renin activity in man. II]. 94
Complessi di Grp94 ed Immunoglobuline G umane 93
Inhibition of immunoglobulin secretion from peripheral blood mononuclear cells by glucose-regulated protein94 (Grp94) inallergic subjects 92
Effects of Glucose-Regulated Protein94 (GRP94) and complexes of GRP94 with IgG on cells of the innate and adaptive immunity (SIF award for the best oral communication) 90
Complexes of Grp94 with human Immunoglobulin G 90
Immune complexes of glucose-regulated protein94 (Grp94) with IgG, present in the plasma of type 1 diabetic subjects, show strong angiogenic-transforming capacity on HUVECs 90
The oxidative mechanism of heparin interferes with radical production by glucose and reduces the degree of glycooxidative modifications on human serum albumin 89
A heat shock protein70 fusion protein with alpha(1)-antitrypsin in plasma of Type 1 diabetic subjects 87
Differential effects of heparin and glucose on structural conformation of human alpha1-antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor. 86
Immune complexes of Glucose-regulated protein94 (Grp94) with IgG are present in the plasma of Type 1 diabetic subjects and show strong angiogenic-transforming capacity on HUVECs (oral communication) 85
Heparin-induced structural and functional alterations of bovine trypsin. 85
Separation by heparin-affinity chromatography of catalytically active and inactive forms of trypsin which retain the (Na-K)ATPase stimulating property. 84
Effects of intact and reduced reducing termini in heparin on structural and functional modifications of trypsin. 83
Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. 83
Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase. 80
Heparin-induced structural modifications and oxidative cleavage of human serum albumin in the absence and presence of glucose. 73
Differential Mechanism for structural and functional alterations of trypsin by heparin, evidence for a speific radical-generating mechanism at low heparin concentrations. 71
Induction of angiogenesis by the heat shock protein Glucose-regulated protein94 (Grp94) mediated by a cytokine-like mechanism. 66
Effects of digoxin on plasma renin activity in hypertensive patients. 66
Inhibition of dopamine beta-hydroxylase by captopril. 63
New insights into the molecular mechanism of heparin-protein interactions. Revisiting the role and function of heparin in the light of its oxidative property 63
Heparin effects on glycated human serum albumin 62
Both a serine-like protease and a protease inhibitory activity are present in circulating immune complexes in type 1 diabetes mellitus. 61
Role of reducing terminals in unfractionated and low-molecular-mass heparins in causing free radical generation and loss of structure and activity of tripsin. 58
IDENTIFICAZIONE DI UNA " GLUCOSE-REGULATED PROTEIN" 94 GRP94 MODIFICATA E USO DELLA STESSA E DI ANTICORPI ANTI-GRP94 NELLE COMPLICANZE VASCOLARI DEL DIABETE 55
Sex and parental hypertension as predictors of worsened red blood cell membrane enzyme activities in type 1 insulin-dependent diabetic subjects. 55
Spin-trapping agent alpha-phenyl N-tert-butylnitrone binds to trypsin and enhances heparin-induced inhibition of amidolytic activity and structural degradation of the enzyme. 54
Spin-trapping agent alpha-phenyl N-Tert-butylnitrone as inhibitor of trypsin and enhancer of the oxidative degradation of the enzyme by heparin 54
Inhibition of enzymes and enzyme by phenothiazines and their radicals. In: Phenothiazienes and 1,4-benzothiazines 53
Purification of proteinase-like and Na+/K(+)-ATPase stimulating substance from plasma of insulin-dependent diabetics and its identification as alpha 1-antitrypsin 47
Totale 4.697
Categoria #
all - tutte 16.008
article - articoli 13.133
book - libri 192
conference - conferenze 0
curatela - curatele 0
other - altro 170
patent - brevetti 571
selected - selezionate 0
volume - volumi 0
Totale 30.074


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021341 0 0 1 32 38 38 9 42 58 22 60 41
2021/2022474 4 64 44 42 21 38 16 47 26 9 45 118
2022/2023454 90 63 12 42 68 76 0 31 41 1 25 5
2023/2024224 17 34 29 19 31 15 18 5 2 3 26 25
2024/2025851 0 37 35 51 138 25 36 63 84 20 150 212
2025/2026734 128 278 328 0 0 0 0 0 0 0 0 0
Totale 4.697